🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Don't let great research stall. With JCF Express: Court of Appeals you can submit your previously reviewed manuscript for an expedited editorial decision. No starting over. No wasted effort. Resubmit today hfsa.org/jcf-express-co…

🫀 ICYMI: JCF is accepting applications for its 2025–26 Reviewer Mentorship Program! ✔️ Early career clinicians ✔️ All specialties welcome ✔️ Open to international applicants 🌍 Apply by May 16 (no extensions!) 🔗 hfsa.org/jcf-reviewer-m…

🖥️AI can play a key role in prev, early detection & treatment of HF, driven by advancements like multimodal LLMs. But challenges like data privacy, system integration, clinician trust & fairness/bias warrant further study. Read the latest Review: bit.ly/3Z9XLhV

New month, new issue! Explore the latest research, reviews, and insights shaping the future of heart failure care in #JCF's May Issue. 🫀 Start reading: bit.ly/3CABnpt

⏳ Time is running out to apply for the JCF 2025–26 Reviewer Mentorship Program! Open to early career clinicians in all specialties, including international applicants. Don't miss out! Applications due by tomorrow May 16th - no exceptions. 🔗 hfsa.org/jcf-reviewer-m…

Steroidal & non-steroidal MRA & aldosterone synthase inhibitors (ASi) are clinically available & being tested in trials. This review evaluates the similarities/differences between these agents & advocates for head-to-head comparisons to guide clinicians. bit.ly/4k0Hd4D

Is uptitration of ARNI in stabilized hospitalized HF pts beneficial? Uptitration Rx led to greater ⬇️ NT-proBNP compared to ARNI w/o uptitration or ACEI/ARB after 8 weeks. In LVEF <40%, ARNI w/wo uptitration led to similar ⬇️ in NT-proBNP. 🔗bit.ly/3YPyHNe

To study HF RPM programs, a multinat'l (USA & India) single-arm trial of pts discharged following HHF was conducted. It showed that RPM ⬆️ NT-proBNP, KCCQ, 6MWT & GDMT utilization. This suggests a pathway to bridge the gap in post-HHF GDMT utilization. 🔗 bit.ly/4jdCMlM

A secondary analysis of the FINEARTS-HF trial examined the effect of finerenone vs. placebo on early readmissions in those randomized during/within 7 days of HHF. It showed that finerenone appeared to favorably influence risk of early HF readmissions. 🔗bit.ly/45pd2PM

Calling all authors! ✍️ There are only 4 weeks left to submit your work for the #JCF Hemodynamics Focus Issue. If your research advances the science of hemodynamics in heart failure, we want to hear from you. Submit your paper today: www2.cloud.editorialmanager.com/cardfail/defau…

I had to miss #HFA2025 in Belgrade to be home with kiddos. Luckily Journal of Cardiac Failure has got me covered with the #ICYMI series recapping all things #FunctionNotFailure Out now! Thank you Jozine ter Maaten Niels Grote Beverborg & team for leading this 🔥 summary!!! onlinejcf.com/article/S1071-…

📖 The June issue is here! Catch up on the latest in heart failure research, reviews & more from the Journal of Cardiac Failure. 🔗 onlinejcf.com/current #HeartFailure #Cardiology #JCF